Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acrocyanosis
advances in neurology
adverse drug reaction
Aicardi-Goutieres syndrome
alemtuzumab
aorta, sheathing
aortitis
arthralgia
ataxia
ataxic gait
atypical
azathioprine
basal ganglia, calcification of
BRAF protooncogene
brain atrophy
brainstem, lesion of
calcification, intracranial
CAT scan, abdomen
CAT scan, abnormal
CAT scan, chest
cerebellar lesion
cerebral cortical atrophy
cerebrospinal fluid, abnormal
chilbran skin lesions
children
chorea
chromosome 3
Churg-Strauss syndrome
Clinical Pathologic Conference(C.P.C.)
cold intolerance
complications
cop 1
cryoglobulinemia
cyclophosphamide
cyclosporine
cyst
cyst, parenchymal
cytokines
daclizumab
dementia
dementia, treatment of
dentate nuclei, lesion of
developmental milestones, loss of
diabetes insipidus
diagnostic criteria
differential diagnosis
diplopia
disability, neurological
dystonia
dystonia, children
efficacy
encephalopathy
Erdheim-Chester disease
evidence-based research
eye movement, disorders of
familial
fatigue
feeding disorder
fever
gadolinium
gene
gene mutation
genetic diagnosis, prenatal
genetic neurologic disorders
Guillain Barre syndrome
head lag
hepatitis
hepatitis C virus
histiocytosis
human T-lymphotropic virus type I(HTLV-I)
hyperpyrexia, CNS disorder causing
hypothalamus
hypothalamus, damage to
hypotonia
iatrogenic neurologic disorders
idiopathic thrombocytopenic purpura
imbalance
immunomodulation
immunosuppression
immunosuppressive agents
insomnia
intellectual deficit
interferon
interferon alpha
interferon beta 1-a
interferon beta 1-b
interferon, intraventricular
intrauterine
irritability
leukodystrophy
leukoencephalopathy
leukopenia
liver disease
liver function enzymes
long bone lesion
microcephaly
misdiagnosis
monoclonal antibodies
mononeuropathy multiplex
mortality
movement disorder
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, serial
MRI, skull bone changes
multiple sclerosis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
myelopathy
natalizumab
neurologic disease, diagnoses of
neuropathology
neuropathy
neuropathy, sensory
neuropathy, vasculitic, nonsystemic
neurotoxic
nonsteroidal anti-inflammatory drug
optic neuropathy
pain
pentoxifylline
pituitary stalk
pituitary stalk, lesion of
pituitary, lesion of
plasmapheresis
pleocytosis of cerebrospinal fluid
pons, lesion of
prenatal
prognosis
progressive multifocal leucoencephalopathy
psychomotor retardation
pyramidal tract dysfunction
radiation therapy, total body
retroperitoneal fibrosis
review article
risk-benefit assessment
sclerosis, bone
skin, biopsy
skin, lesions in neurologic disorders
somnolence
spastic diplegia
speech disorder, childhood
startle reaction
steroid therapy, CNS treatment and complications with
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
suprasellar lesion
T cell lymphocytes
treatment of neurologic disorder
tumor necrosis factor
tumor necrosis factor inhibitor
vasculitides
viral infection
walking frame
white matter disease
Showing articles 150 to 200 of 519 << Previous Next >>

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

Acute Unilateral Hearing Loss as an Early Symptom of Lateral Cerebral Sinus Venous Thrombosis
Arch Neurol 69:1508-1511, Gattringer, T.,et al, 2012

PML-IRIS in a patient treated with Brentuximab
Neurol 79:2075-2077, Geldern, G.,et al, 2012

Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012

Late onset autism and anti-NMDA-receptor encephalitis
Lancet 378:98;378, Creten, C.,et al, 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Cost-effectiveness of disease-modifying therapy for multiple sclerosis
Neurol 77:355-363, Noyes, K.,et al, 2011

Encephalitis Associated with Glutamic Acid Decarboxylase Autoantibodies in a Child A Treatable Condition?
Arch Neurol 68:1065-1068, Korff, C.M.,et al, 2011

Optic Neuritis: Prognosis and Treatment
UpToDate, Jan, Osborne, B.,et al, 2011

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
Arch Neurol 68:1156-1164, Clifford, D.B.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Clinicopathologic Conference, Limbic Encephaitis with Antibodies to Leucine - Rich Glioma - inactivated 1 (LGI 1).
NEJM 365:1825-1833, Case 34-2011, 2011

Hypereosinophilia in Patients with Multiple Sclerosis Treated with Natalizumab
Neurol 77:1561-1564, Abbas, M.,et al, 2011

Multiple Sclerosis-Quenching the Flames of Inflammation
Lancet 378:1759-1760, , 2011

Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS
Neurol 77:2010-2016, Kuhle, J.,et al, 2011

Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis
Neurol 77:2128-2134, Scott, T.F.,et al, 2011

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma
Neurol 76:929-930, Batchelor,T.T.,et al, 2011

Rituximab in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Report of 13 Cases and Review of the Literature
JNNP 82:306-308, Benedetti,L.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011

Use and monitoring of low dose rituximab in myasthenia gravis
JNNP 82:659-663, Blum, S., et al, 2011

Severe Cutaneous Candida Infection During Natalizumab Therapy in Multiple Sclerosis
Neurol 74:521-523, Gutwinski,S.,et al, 2010

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010

Reversible Paraneoplpastic Limbic Encephalitis Associated with Antibodies to the AMPA Receptor
Neurol 74:265-267, Bataller,L.,et al, 2010

Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010

Response to Immunotherapy in a 20-Month-Old Boy With Anti-NMDA Receptor Encephalitis
Neurol 74:1550-1551, Wong-Kisiel,L.C., et al, 2010

Posterior Reversible Encephalopathy Syndrome After Rituximab Infusion in Neuromyelitis Optica
Neurol 74:1471-1473, S�nchez-Carteyron,A., et al, 2010

Treatment of Refractory Neurosarcoidosis with Infliximab
JNNP 81:241-246, Santos,E., et al, 2010

Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010

A Case of Neurosarcoidosis Successfully Treated with Rituximab
Neurol 75:568-570, Bomprezzi,R., et al, 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

Safety and Efficacy of Natalizumab in Children With Multiple Sclerosis
Neurol 75:912-917, Ghezzi,A.,et al, 2010

Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010

Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010

Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010

(-Synuclein Accumulation in Skin Nerve Fibers Revealed by Skin Biopsy in Pure Autonomic Failure
Neurol 74:608-610,536, Shishido,T.,et al, 2010

Acute Toxoplasmosis Infection in a Patient with Ankylosing Spondylitis Treated with Adalimumab: A Case Report
Reumatismo 62:283-285, Azevedo V.F., et al, 2010

Pregnancy and Fetal Outcomes After Interferon-b Exposure in Multiple Sclerosis
Neurol 75:1794-1802, Amato,M.P.,et al, 2010

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010

Isolated Vein Thrombosis of the Posterior Fossa Presenting as Localized Cerebellar Venous Infarctions or Hemorrhages
Stroke 41:2358-2361, Ruiz-Sandoval, J.L.,et al, 2010

What if the sexual headache is not a joke?
BJMP 3:304-308, Redelman, M., 2010

May-Thurner Syndrome in Patients with Cryptogenic Stroke and Patent Foramen Ovale
Stroke 40:1502-1504, Kiernan, T.J.,et al, 2009

Long-Term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-a-Blocker Therapy
JAMA Neurol 66:490-497, Lozeron, P.,et al, 2009

Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor- Inhibitors
CID 49:924-927, Bradford, R.D.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Migraine and Cardiovascular Disease: Systematic Review and Meta-Analysis
BMJ 339:b3914, Sch�rks,M.,et al, 2009

Isolated Lateral Sinus Thrombosis: A Series of 62 Patients
Stroke 40:476-481, Damak,M.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009



Showing articles 150 to 200 of 519 << Previous Next >>